Preoperative chemoradiotherapy versus postoperative chemoradiotherapy for stage II-III resectable rectal cancer: a meta-analysis of randomized controlled trials
Jin Ho Song, Jae Uk Jeong, Jong Hoon Lee, Sung Hwan Kim, Hyeon Min Cho, Jun Won Um, Hong Seok Jang,
Radiat Oncol J. 2017;35(3):198-207.   Published online 2017 Sep 15     DOI: https://doi.org/10.3857/roj.2017.00059
Citations to this article as recorded by Crossref logo
MRI-based Multiregional Radiomics for Pretreatment Prediction of Distant Metastasis After Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer
Rui Zhao, Lijuan Wan, Shuang Chen, Wenjing Peng, Xiangchun Liu, Sicong Wang, Lin Li, Hongmei Zhang
Academic Radiology.2024; 31(4): 1367.     CrossRef
The pattern of bowel dysfunction in patients with rectal cancer following the multimodal treatment: anorectal manometric measurements at before and after chemoradiation therapy, and postoperative 1 year
Ri Na Yoo, Bong-Hyeon Kye, HyungJin Kim, Gun Kim, Hyeon-Min Cho
Annals of Coloproctology.2023; 39(1): 32.     CrossRef
Dynamic radiomics for predicting the efficacy of antiangiogenic therapy in colorectal liver metastases
Hui Qu, Huan Zhai, Shuairan Zhang, Wenjuan Chen, Hongshan Zhong, Xiaoyu Cui
Frontiers in Oncology.2023;[Epub]     CrossRef
Total neoadjuvant treatment to increase the clinical complete response rate for distal locally advanced rectal cancer (TESS): A study protocol of a prospective, open‐label, multicenter, single‐arm, phase 2 trial
Shuang Liu, XiaoZhong Wang, YeZhong Zhuang, ShouMin Bai, XiaoJun Wu, YiJing Ye, HuiLong Luo, HaiNa Yu, QiaoXuan Wang, Hui Chang, ZhiFan Zeng, PeiQiang Cai, ZhiZhong Pan, YuanHong Gao, Gong Chen, WeiWei Xiao
Cancer Medicine.2023; 12(12): 13352.     CrossRef
Applying a neoscore in locally advanced rectal cancer is beneficial in predicting local recurrences after surgery
Amal Rayan, Ahmed Soliman, Norikatsu Miyoshi
PLOS ONE.2023; 18(5): e0285709.     CrossRef
One-Week versus Two-Week Chemoradiotherapy Followed by Curative Surgery in Rectal Cancer: Long-Term Comparative Pooled Analysis of Two Prospective Multicenter Phase II Trials
Soo-Yoon Sung, Dae Yong Kim, Hong Seok Jang, Tae Hyun Kim, Hee Chul Park, Eui Kyu Chie, Taek-Keun Nam, Sung Hwan Kim, Jong Hoon Lee
Cancer Research and Treatment.2023; 55(3): 918.     CrossRef
Implication of MRI Risk Stratification System on the Survival Benefits of Adjuvant Chemotherapy After Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer
Rui Zhao, Wei Zhao, Yumeng Zhu, Lijuan Wan, Shuang Chen, Qing Zhao, Xinming Zhao, Hongmei Zhang
Academic Radiology.2023; 30: S164.     CrossRef
Investigating anorectal function using postoperative MRI-based fibrosis score in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy: a two-center study
Yuan Yuan, Yue Yu, Yi Qun Sun, Shuai Li, Hai Di Lu, Xiao Lu Ma, Jian Ping Lu, Cheng Wei Shao, Wei Zhang, Tong Tong, Xian Hua Gao, Fu Shen
Annals of Medicine.2023;[Epub]     CrossRef
Oxaliplatin-based adjuvant chemotherapy rather than fluorouracil-based chemotherapy in rectal cancer is more efficient to decrease distant metastasis and increase survival after preoperative chemoradiotherapy and surgery: a meta-analysis
Jin Ho Song, Jong Hoon Lee, Sung Hwan Kim, Jun Won Um
International Journal of Colorectal Disease.2022; 37(3): 649.     CrossRef
Postoperative hypofractionated–accelerated radiotherapy (HypoAR) for locally advanced rectal cancer
Michael I Koukourakis, Christos Kavazis, Axiotis Giagtzidis, Panagiotis Mamalis, Alexandra Tsaroucha, Sotirios Botaitis, Alexandra Giatromanolaki, Michael Pitiakoudis
Japanese Journal of Clinical Oncology.2022; 52(5): 493.     CrossRef
Treatment options for rectal cancer
Filip Pazdírek, Michal Vjaclovský, Marek Grega, Jiří Hoch
Onkologie.2022; 16(1): 33.     CrossRef
Pretreatment blood biomarkers combined with magnetic resonance imaging predict responses to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
Xinyu Shi, Min Zhao, Bo Shi, Guoliang Chen, Huihui Yao, Junjie Chen, Daiwei Wan, Wen Gu, Songbing He
Frontiers in Oncology.2022;[Epub]     CrossRef
Pathologic Implications of Radial Resection Margin and Perineural Invasion to Adjuvant Chemotherapy after Preoperative Chemoradiotherapy and Surgery for Rectal Cancer: A Multi-Institutional and Case-Matched Control Study
Soo-Yoon Sung, Sung Hwan Kim, Hong Seok Jang, Jin Ho Song, Songmi Jeong, Ji-Han Jung, Jong Hoon Lee
Cancers.2022; 14(17): 4112.     CrossRef
Correlation between T stage and lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy
Seijong Kim, Jung Wook Huh, Woo Yong Lee, Seong Hyeon Yun, Hee Cheol Kim, Yong Beom Cho, Yoonah Park, Jung Kyong Shin
Therapeutic Advances in Medical Oncology.2022; 14: 175883592211326.     CrossRef
MRI-defined high-risk rectal cancer patients: outcome comparison between neoadjuvant chemoradiotherapy plus TME and TME plus adjuvant chemotherapy or TME alone
Xiaoxuan Jia, Peiyi Xie, Liang Bi, Xiaochun Meng, Ziqiang Wang, Nan Hong, Yi Wang
The British Journal of Radiology.2021; 94(1120): 20201221.     CrossRef
Magnetic resonance imaging-radiomics evaluation of response to chemotherapy for synchronous liver metastasis of colorectal cancer
Yan-Qing Ma, Yang Wen, Hong Liang, Jian-Guo Zhong, Pei-Pei Pang
World Journal of Gastroenterology.2021; 27(38): 6465.     CrossRef
Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline
Jennifer Y. Wo, Christopher J. Anker, Jonathan B. Ashman, Nishin A. Bhadkamkar, Lisa Bradfield, Daniel T. Chang, Jennifer Dorth, Julio Garcia-Aguilar, David Goff, Dustin Jacqmin, Patrick Kelly, Neil B. Newman, Jeffrey Olsen, Ann C. Raldow, Erika Ruiz-Garc
Practical Radiation Oncology.2021; 11(1): 13.     CrossRef
Short-term outcomes of laparoscopic intersphincteric resection with intraoperative radiotherapy using low-energy X-rays for primary locally advanced low rectal cancer: a single center experience
Wangsheng Xue, Shuang Wang, Zeyun Zhao, Yongbo Li, An Shang, Donglin Li, Jianzheng Yang, Tiejun Wang, Min Wang
World Journal of Surgical Oncology.2020;[Epub]     CrossRef
Carcinoembryonic Antigen Improves the Performance of Magnetic Resonance Imaging in the Prediction of Pathologic Response after Neoadjuvant Chemoradiation for Patients with Rectal Cancer
Gyu Sang Yoo, Hee Chul Park, Jeong Il Yu, Doo Ho Choi, Won Kyung Cho, Young Suk Park, Joon Oh Park, Ho Yeong Lim, Won Ki Kang, Woo Yong Lee, Hee Cheol Kim, Seong Hyeon Yun, Yong Beom Cho, Yoon Ah Park, Kyoung Doo Song, Seok-Hyung Kim, Sang Yun Ha
Cancer Research and Treatment.2020; 52(2): 446.     CrossRef
Gastrointestinal Cancers: Moving the Needle for Rectal, Gastroesophageal, Pancreaticobiliary, and Liver Cancers
Jordan Kharofa, Christopher L. Hallemeier, Florence Huguet, Christopher J. Anker, Michael H. Buckstein, Diana Tait, Jeffrey R. Olsen, Salma K. Jabbour
International Journal of Radiation Oncology*Biology*Physics.2020; 106(4): 653.     CrossRef
Neoadjuvant radiotherapy improves overall survival for T3/4N+M0 rectal cancer patients: a population-based study of 20300 patients
Feng Zhao, Jili Wang, Hao Yu, Xiaofei Cheng, Xinke Li, Xuan Zhu, Xiangming Xu, Jianjiang Lin, Xin Chen, Senxiang Yan
Radiation Oncology.2020;[Epub]     CrossRef
Dose–time fractionation schedules of preoperative radiotherapy and timing to surgery for rectal cancer
Fu Jin, Huanli Luo, Juan Zhou, Yongzhong Wu, Hao Sun, Hongliang Liu, Xiaodong Zheng, Ying Wang
Therapeutic Advances in Medical Oncology.2020; 12: 175883592090753.     CrossRef
Current Options in the Management of Colorectal Cancer in Developing Countries: Central America Experience
Anny Ochoa-Hernandez, Karen Giron, Jennie Meier, Ana Paulina Charchalac
Current Colorectal Cancer Reports.2020; 16(3): 49.     CrossRef
Total Neoadjuvant Therapy for Rectal Cancer: Current Status and Future Directions
Jay C. Shiao, Kareem Riadh Fakhoury, Jeffrey Olsen
Current Colorectal Cancer Reports.2020; 16(6): 125.     CrossRef
Nadir/pre-chemoradiotherapy ratio of white blood-cell count can predict tumor response and recurrence-free survival in locally advanced rectal cancer: a multi-institutional analysis
Joo Hwan Lee, Jae Uk Jeong, Sung Hwan Kim, Taek Keun Nam, Jong Hoon Lee, Songmi Jeong, Mina Yu, Hong Seok Jang
International Journal of Colorectal Disease.2019; 34(1): 105.     CrossRef
Pathologic Staging Inconsistency Between ypT4N0 (stage II) and ypT1-2N1 (stage III) After Preoperative Chemoradiotherapy and Total Mesorectal Excision in Rectal Cancer: A Multi-Institutional Study
Joo Hwan Lee, Mina Yu, Sung Hwan Kim, Jong Hoon Lee, Soo-Yoon Sung, Bae Kwon Jeong, Songmi Jeong, Taek Keun Nam, Jae Uk Jeong, Hong Seok Jang
Clinical Colorectal Cancer.2019; 18(1): e130.     CrossRef
Adjuvant Chemotherapy in Rectal Cancer Patients Treated With Preoperative Chemoradiation and Total Mesorectal Excision: A Multicenter and Retrospective Propensity-Score Matching Study
Mi Joo Chung, Joo Hwan Lee, Jong Hoon Lee, Sung Hwan Kim, Jin Ho Song, Songmi Jeong, Mina Yu, Taek Keun Nam, Jae Uk Jeong, Hong Seok Jang
International Journal of Radiation Oncology*Biology*Physics.2019; 103(2): 438.     CrossRef
Significance of perineural and lymphovascular invasion in locally advanced rectal cancer treated by preoperative chemoradiotherapy and radical surgery: Can perineural invasion be an indication of adjuvant chemotherapy?
Jin Ho Song, Mina Yu, Ki Mun Kang, Jong Hoon Lee, Sung Hwan Kim, Taek Keun Nam, Jae Uk Jeong, Hong Seok Jang, Jeong Won Lee, Ji-Han Jung
Radiotherapy and Oncology.2019; 133: 125.     CrossRef
MRI for Restaging Locally Advanced Rectal Cancer: Detailed Analysis of Discrepancies With the Pathologic Reference Standard
Xiaoxuan Jia, Yinli Zhang, Yi Wang, Caizhen Feng, Danhua Shen, Yingjiang Ye, Nan Hong
American Journal of Roentgenology.2019; 213(5): 1081.     CrossRef
Oncologic Risk of Rectal Preservation Against Medical Advice After Chemoradiotherapy for Rectal Cancer: A Multicenter Comparative Cross‐Sectional Study with Rectal Preservation as Supported by Surgeon
Kwang‐Seop Song, Sung Chan Park, Dae Kyung Sohn, Jae Hwan Oh, Min Jung Kim, Ji Won Park, Seung‐Bum Ryoo, Seung‐Yong Jeong, Kyu Joo Park, Heung‐Kwon Oh, Duck‐Woo Kim, Sung‐Bum Kang
World Journal of Surgery.2019; 43(12): 3216.     CrossRef
The role of chemotherapy in localized and locally advanced rectal cancer: A systematic revision
Susana Roselló, Federica Papaccio, Desamparados Roda, Noelia Tarazona, Andrés Cervantes
Cancer Treatment Reviews.2018; 63: 156.     CrossRef
Current Trends in the Rate of Rectal Cancer Restorative Operations in the Era of Neoadjuvant Chemoradiation
Holly B. Cunningham, Joshua J. Weis, Luis R. Taveras
Current Colorectal Cancer Reports.2018; 14(1): 31.     CrossRef
Advances in Radiotherapy for Locally Advanced Rectal Cancer
晓萌 纪
Advances in Clinical Medicine.2018; 08(01): 59.     CrossRef
Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy in rectal cancer treated with neoadjuvant concurrent chemoradiation: a meta-analysis and pooled-analysis of acute toxicity
Chan Woo Wee, Hyun-Cheol Kang, Hong-Gyun Wu, Eui Kyu Chie, Noorie Choi, Jong Min Park, Jung-in Kim, Chun-Ming Huang, Jaw-Yuan Wang, Shu Y Ng, Karyn A Goodman
Japanese Journal of Clinical Oncology.2018; 48(5): 458.     CrossRef
Comparative survival analysis of preoperative and postoperative radiotherapy in stage II-III rectal cancer on the basis of long-term population data
Yu Jin Lim, Youngkyong Kim, Moonkyoo Kong
Scientific Reports.2018;[Epub]     CrossRef
Total mesorectal excision with or without preoperative chemoradiotherapy for resectable mid/low rectal cancer: a long‐term analysis of a prospective, single‐center, randomized trial
Fulong Wang, Wenhua Fan, Jianhong Peng, Zhenhai Lu, Zhizhong Pan, Liren Li, Yuanhong Gao, Hui Li, Gong Chen, Xiaojun Wu, Peirong Ding, Zhifan Zeng, Desen Wan
Cancer Communications.2018; 38(1): 1.     CrossRef